Market Dashboard
- You are here:
- Home
- Markets
- Market Dashboard
- Glenmark Pharmaceuticals Ltd.
NSE Symbol: | BSE Code: | ISIN: | Sector:
- Add to Portfolio
- Add to Watchlist
- Add to Alert
- Add to Message
Add to Portfolio
NSE
636.05
| Change | Change % |
| -27.00 | -4.07% |
Updated:09 Jun, 2023, 15:58 PM IST |
|
BSE
636.05
| Change | Change % |
| -26.95 | -4.06% |
Updated:09 Jun, 2023, 16:01 PM IST |
|
Previous Close
Day's Open
Volume Traded (in 000's)
Value Traded (in Cr)
Day's Range
634.15659.10
52 Wk Range
457.00 711.55
Compare Price performance of vs. Peer Companies
From sector
Compare with Peers on Key Fundamentals and Financials
- SUNPHARMA
-3.07% - DIVISLAB
-3.26% - CIPLA
0.85% - DRREDDY
-0.04% - CADILAHC
-1.52% - ABBOTINDIA
-0.29% - ALKEM
0.16% - AUROPHARMA
-0.48% - LUPIN
-1.37% - TORNTPHARM
0.27% - BIOCON
-1.11% - GLAXO
-1.04% - PFIZER
-0.51% - GLENMARK
-4.06% - JBCHEPHARM
0.08% - SANOFI
-2.44% - PEL
-1.24% - AJANTPHARM
0.62% - NATCOPHARM
0.02% - APLLTD
5.20% - IPCALAB
-2.35% - ERIS
-0.80% - ASTRAZEN
-0.48% - MERCK
-3.78% - GRANULES
-2.31% - CAPLINLABS
2.93% - FDC
0.44% - HIKAL
-1.66% - MARKSANS
-0.30% - LAURUSLABS
-2.18%
's Latest Research Report
| Brokerage/Analyst | Report Date | Call | Price@Call | Target | Current Status | Report |
|---|---|---|---|---|---|---|
| Nomura - |
12-07-2019 | Buy | 450.60 | 867.00 | Closed | Details |
| Edelweiss - |
06-11-2017 | Hold | 626.75 | 670.00 | Target Hit | Details |
| Nomura - |
30-08-2017 | Buy | 615.00 | 856.00 | Closed | Details |
| Nomura - |
02-08-2017 | Buy | 701.80 | 966.00 | Closed | Details |
| Credit Suisse - |
03-02-2017 | Hold | 954.75 | 925.00 | Target Hit | Details |
More from Research Reports »
Glenmark Pharma's Key Fundamentals
| Parameter | Values |
|---|---|
| Market Cap (in ₹ Cr.) | 17,947.30 |
| Earning Per Share (EPS TTM) (₹) | 57.48 |
| Price To Earnings (P/E) Ratio | 11.07 |
| Book Value Per Share (₹) | 367.90 |
| Price To Books (P/B) Ratio | 1.73 |
| EBIT Margin (%) | 21.92 |
| PAT Margin (%) | 15.77 |
| ROCE (%) | 11.02 |
| PAT Growth (%) | -52.61 |
| Total Debt to Equity (D/E) Ratio | 0.29 |
More from Key Fundamentals »
Glenmark Pharma's Financial Summary
| Parameter | MAR'18 (₹ Cr.) |
MAR'17 (₹ Cr.) |
YoY %Change |
|---|---|---|---|
| Balance Sheet: | |||
| Share Capital | 28.22 | 28.22 | 0.00% |
| Total Non-Current Liabilities | 3,290.08 | 2,989.08 | 10.07% |
| Total Current Liabilities | 3,113.04 | 2,898.67 | 7.40% |
| Total Liabilities | 16,794.57 | 15,324.37 | 9.59% |
| Total Non-Current Assets | 9,991.07 | 8,447.04 | 18.28% |
| Currents Investments | 0.00 | 0.00 | 0.00% |
| Cash and Bank | 177.38 | 252.18 | -29.66% |
| Total Current Assets Excluding Current Investments | 6,803.49 | 6,877.32 | -1.07% |
| Total Assets | 16,794.57 | 15,324.37 | 9.59% |
| Profit and Loss: | |||
| Gross Sales | 6,431.88 | 8,095.50 | -20.55% |
| Net Sales | 6,403.23 | 7,989.23 | -19.85% |
| PBIDT (Excl OI) | 1,347.50 | 2,898.64 | -53.51% |
| PAT | 1,014.35 | 2,140.61 | -52.61% |
More from Financial Summary »
Glenmark Pharma's Shareholding Pattern
| Description | Percent of Share (%) |
|---|---|
| Promoters | 48.27 |
| Individuals | 9.53 |
| Institutions | 4.60 |
| FII | 34.91 |
| Govt. | 0.00 |
| Others | 2.69 |
More from Holding Pattern »
Glenmark Pharma held by Mutual Fund Schemes
More from Mutual Fund Holding »
's Futures and Options Quotes
| Contract Expiry Date |
Type | Current price | Change | Change % | Premium / Discount |
|---|---|---|---|---|---|
| GLENMARK 29-06-2023 |
FUTSTK |
639.50 | -10.70 | -1.65% | 3.45 |
| GLENMARK 27-07-2023 |
FUTSTK |
641.40 | -10.70 | -1.64% | 5.35 |
| GLENMARK 31-08-2023 |
FUTSTK |
643.00 | -13.00 | -1.98% | 6.95 |
More from Futures and Options Quotes »
..